Praziquantel (PZQ), sold under the brandname Biltricide among others, is a medication used to treat a number of types of parasitic worm infections. Specifically it is used for schistosomiasis, clonorchiasis, opisthorchiasis, tapeworm infections, cysticercosis, hydatid disease, and other fluke infections. It should not be used for worm infections of the eye.
Market Analysis and Insights: Global Praziquantel Market
Due to the COVID-19 pandemic, the global Praziquantel market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Patent accounting for % of the Praziquantel global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cestode Infections segment is altered to an % CAGR throughout this forecast period.
China Praziquantel market size is valued at US$ million in 2021, while the US and Europe Praziquantel are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Praziquantel landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Praziquantel include Bayer, Zoetis, Richter Pharma, Chanelle Pharma, Covetrus, Shin Poong Pharm, Merial, Norbrook Laboratories and AniMedica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Praziquantel Scope and Segment
Praziquantel market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Praziquantel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Patent
Generic
Segment by Application
Cestode Infections
Cysticercosis
Liver Fluke Infection
Trematode Infections
Schistosoma Infection
Others
By Company
Bayer
Zoetis
Richter Pharma
Chanelle Pharma
Covetrus
Shin Poong Pharm
Merial
Norbrook Laboratories
AniMedica
Kyron Pharma
Ecuphar
Lavet Pharmaceuticals
Krka
Auvex
Mavlab Animal Health
Ceva Santé Animale
Soparfin
C and H Generics
CiplaVet
Merck
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE